Randomized controlled study of mitomycin C/carboquone/5-fluorouracil/ OK-432 (MQ-F-OK) therapy and mitocyin C/5-fluorouracil/doxorubicin (FAM) therapy against advanced liver cancer

Author(s): Sakata, Y., Komatsu, Y. , Takagi, S. , Saitho, S. , Itoh, T. , Suzuki, H. , Tsushima, K. , Sasaki, D. , Yoshida, Y.

Journal/Book: CAncer Chemother Pharmacol. 1989; 23: 9-12.

Keyword(s): krebs. ok-432